Bibliography

Abel, Marijuana, The First Twelve Thousand Years. New York: Plenum Publishing Corporation, 1980

Abrahamov, Abrahamov, and Mechoulam, “An efficient new cannabinoid anti-emetic in pediatric oncology.” The Brettler Center for Medical Research, Hebrew University, Jerusalem. Source: Journal of the International Hemp Association. Vol. 2, No. 2, pp. 76-79

Abrams, Lindesmith Center Lecture, San Francisco, May 17, 1999

Abrams. “Marijuana does not appear to alter viral loads of HIV patients taking protease inhibitors.” University of California, July 13, 2000. Source: Cannabis MD Reports, www.cannabismd.org/reports/abrams1.php.

“AIDS cases up dramatically among Americans 50 and up.” Newsday, January 23, 1998

“AIDS drugs fail many.” Seattle Times, September 30, 1997

Aigner, “Delta-9 tetahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeys.” Psychopharmacology, Vol. 95, No. 4, pp. 507-511, 1988

Alliance for Cannabis Therapeutics, ACT News. Spring 1995, ACT, PO Box 19161, Sarasota, FL 34276

American Civil Liberties Union statement on marijuana prohibition, May, 1998

“American Medical Association House of Delegates Report.” December 9, 1997, Source: Marijuana Policy Project, www.mpp.org

American Psychiatric Association, Desk Reference to the Diagnostic Criteria from DSM-3-R

Anecdotal reports from the Sonoma Alliance for Medical Marijuana, 1998

Annas, “Reefer madness—the federal response to California’s medical marijuana law.” The New England Journal of Medicine. Vol. 337, No. 6, August 7, 1997

Armentano, “Barry Frank submits new Med-MJ proposal.” High Times, No. 287, July 1999

Armentano, “Pot Doesn’t Rot Your Brain.” High Times, No. 290, October 1999

Amtmann, Weydt, Johnson, Jensen, and Carter. “Survey of Cannabis Use in Patients with Amyotrophic Lateral Sclerosis.” Source: Cannabis MD, www.cannabismd.org/reports/carter4.php

“Ask Andrew Weil.” Health questions answered online, www.pathfinder.com/drweil/

Avakian, Horvath, Michael, and Jacobs, “Effects of marijuana on cardio-respiratory responses to submaximal exercise.” Clinical Pharmacological Therapeutics, Vol. 6, pp. 777-781, 1979. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/PubMed/

Axelrod, “Enzymatic synthesis of anandamide, an endogenous liand for the cannabinoid receptor, by brain membranes.” Laboratory of Cell Biology, National Institute of Mental Health, Bethesda MD. Source: Proctor of the National Academy of Science, Vol. 14, pp. 698-701, July 5, 1991

Barnell, “Marijuana and spastic paraplegia.” Source: Grinspoon.

Baron and Folan, “Ulcerative colitis and marijuana.” Annals of Internal Medicine, Vol. 112, No. 6, p. 471, Dartmouth-Hitchcock Medical Center, Hanover, NH, March 15, 1990

Baum, Smoke and Mirrors. New York: Little, Brown and Company, 1997

Beltramo and Piomelli, “Functional role of high-affinity anandamide transport, as revealed by selective inhibition.” Science, Vol. 277, No. 5329, p. 1094(4), 1997

Bertrand, Affidavit before Ontario Court (Canada) in the case of Christopher Clay. Source: www.hempnation.com/challenge/bertrand.html

“Big increase in rate of prescription drugs.” Associated Press, February 18, 1998

Borger, “Marijuana substitute combats nerve gas.” Scripps Howard News, July 22, 1998. Source: Cowen, www.marijuananews.com

Brenneisen, “Pharmacokinetics.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 6, p. 67-68, 70, 73

The Brown University Digest of Addiction Theory and Application. Vol. 15, No. 11, p. 7, November 1997, Electronic Collection: A20104041

Buckley, “Is marijuana fear a myth?” National Review, August 24, 1997

California NORML Reports, Vol. 21, No. 3, 1997, CANORML, 2215-R Market Street #278, San Francisco, CA 94114, www.norml.org/canorml

California NORML Reports, Vol. 23, March, 1999

California Research Advisory Panel, 1990

Campbell, The Power of Myth. New York: Doubleday, 1988

Campbell III, ed. Psychiatry News (Newspaper of the American Psychiatric Association), April 16, 1999. Source: www.appi.org/pnews

“Cannabidiol: Wonder drug of the 21^st century?” Source: Schaffer Library of Drug Policy, www.druglibrary.org

“Cannabis: Look, Learn, Listen.” Independent (UK), cannabis@independentco.org, 1998. Source: Media Awareness Project, www.mapinc.org

Capaldina, Tashkin, Vilensky, and Talarico, “Does marijuana have a place in medicine?” Patient Care, Vol. 32, No. 2, p. 41, January 1998

Carter, Aggarwal, Steinborn, “Clearing the Air: What the Latest Supreme Court Ruling Really Means Regarding Medical Marijuana.” Am J Hosp Palliat Care, Vol. 22, No. 5, pp.327-329, 2005. Source: PubMed PMID: 16225351

Carter, Chinn, Steinborn. “The Latest Buzz on Medicinal Marijuana: A Legal and Medical Perspective.” Source: Cannabis MD, http://www.cannabismd.org/reports/carter1.php.

Carter, Rosen. “Marijuana In The Management of Amyotrophic Lateral Sclerosis.” Source: Cannabis MD, http://www.cannabismd.org/reports/carter2.php.

Carter, Weydt. Abrams, “Rational Guidelines for Dosing” Department of Rehabilitation and Department of Neurology, Unversity of Washington School of Medicine, Seattle, WA 98531, gtcarter@u.washington.edu

Carter, Weydt. “Cannabis: Old medicine with new promise for neurological disorders” Department of Rehabilitation and Department of Neurology, Unversity of Washington School of Medicine, Seattle, WA 98531, gtcarter@u.washington.edu

Castaneda, et al., “THC does not affect striatal dopamine release: microdialysis in freely moving rats.” 1991. Source: Gettman, Marijuana, Science, and Public Policy, 1991, www.norml.org/facts/mspp.sthml

Cavanaugh, Ph.D. “Clubs for Medicinal Cannabis”

“Chocolate and Cannabinol.” The Washington Post, August 26, 1996

“CDC says a third of HIV cases untreated.” Associated Press, September 26, 1997

“CMA backs removal of marijuana from Schedule I prohibitive status.” NORML News, May 28, 1998. Source: NORML, 1001 Connecticut Avenue Northwest #1010, Washington, DC 20036, www.norml.org

Commission of Inwuiry into the Non-medical Use of Drugs. Ottawa: Information Canada, 1972

Cone and Johnson, “Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.” Clinical Pharmacological Therapy, Vol. 40, No. 3, pp. 247-256, September 1986

Cone, Johnson, Moore, and Roache, “Acute effects of smoking marijuana on hormones, subjective effects, and performance in male human subjects.” Pharmacology and Biochemical Behavior, Vol. 24, No. 6, pp. 1749-1754, June 1986

Conrad, “Hemp: The Natural Flower of Health.” Source: Mount, ed. Cannabis and Childbirth. Source: www.snowcrest.net/stlight

Conrad, Hemp for Health. Rochester, Vermont: Healing Arts Press, 1997

Conrad, Hemp: Lifevine to the Future. Lost Angeles: Creative Xpressions Publications, 1993

Consensus statement of the European Association for the Study of Liver Disease. International Consensus Conference on Hepatitis C, Paris, February 1999

Consroe, Stern, and Snyder, “Effectgs of Cannabidiol in Huntington’s Disease.” Neurology, Vol. 36 (Suppl 1), p. 342, April 1986

Conversations with Rob Killian, MD, 1998

Conversations with Elvy Musikka, federally authorized medical marijuana patient, 1997-1999

Conversations with double board-certified psychiatrist Francis Podrebarac, MD, 1998-1999

Cowen, “Science journal reports that cannabinoid receptors located outside the brain and spine are affected when the skin or flesh is cut or hurt.” July 16, 1998. Source: www.marijuananews.com

Cuhna, et al., “Chronic administration of cannabidiol to healthy volunteers and epileptic patients.” Pharmacology, Vol 21, 1980

“DEA Refers Marijuana Rescheduling Petition to HHS.” The Law Offices of Michael Kennedy, NY, 1998

“Deaths from drug errors rise sharply for outpatients.” The Seattle Times, February 28, 1998

“Deferne and Pate, “Hemp Seed Oil: A source of valuable essential fatty acids.” Journal of the International Hemp Association, Vol. 3, No. 1, pp. 4-7, 1996

Degenhardt, Louisa, PhD and Hall, Wayne D., PhD "The adverse effects of cannabinoids: implications for use of medical marijuana”  CMAJ • June 17, 2008; 178 (13). doi:10.1503/cmaj.080585.© 2008 Canadian Medical Association or its licensors

“Deglamorizing cannabis.” Editorial, The Lancet, Vol. 346, No. 8985, p. 1241, November 11, 1995

Devane, et al., Science, Vol. 258, pp. 1946-1949, 1992

Diabetic reports from Seattle and from the Sonoma Alliance for Medical Marijuana, 1998

“Diagnosis: smoke pot to relieve pain.” The University of Washington Daily, May 1997

Dittrich, Maurer, Henn, and Hoffman, “Delta-9 tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.” European Archive of Psychiatry and Neurological Science, Vol. 240, No. 1, pp. 1-4, 1990

Doblin and Kleiman, “Marijuana as anti-emetic medicine: A survey of oncologists experiences and attitudes.” Journal of Clinical Oncology, Vol. 9, pp. 1314-1319, 1991

“Doctors urge war on pain, more use of opium-based drugs.” Miami Hearald, January 29, 1998

Dreher, Nugent, and Hudgkins, “Parental marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study.” Pediatric, Vol. 93, No. 2, pp. 254-260, February 1994, School of Nursing, Education, and Public Health, University of Massachusetts, Amhearst

Drug Enforcement Administration, Statement of Policy for the Use and Handling of Controlled Substances in the Treatment of Pain, 1998

Drug Policy Foundation, 4455 Connecticut Avenue Northwest #B-500, Washington, DC 20008, www.dpf.org

“Drug reactions kill more than 100,000.” Associated Press, May 14, 1998

Eaton, “What you don’t know can kill you.” 1998. Source: Cowen, www.marijuananews.com

Edmunson, Project Leader, “Environmental analysis and documentation.” USDA/AHPIS/PPD, 4700 River Road, Unit 149, Riverdale, MD 20737-1238. Source: Colorado Hemp Initiative Project, PO Box 729, Nederland, CO, www.welcomehome.org/cohip

Edwards, MD., Testimony before the National Academy of Sciences in New Orleans, January 1998

Egelco, “Federal judge orders closure of six Northern California pot clubs.” Associated Press, May 14, 1998

Egli, Elsohly, Henn, and Spiess, “The effect of orally and rectally administered delta-9-tetrahydrocannbinol on spasticity: A pilot study with two patients.” International Journal of Clinical Pharmacology, Vol. 34, No. 10, pp. 446-452, 1988

Ekert, Waters, Jurk, Mobilia, and Loughnan, “Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydocannabinol.” Medical Journal of Australia, Vol. 2, No. 12, pp. 657-659, December 15, 1979. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Ronald J Ellis1, Will Toperoff1, Florin Vaida2, Geoffrey van den Brande3, James Gonzales4, Ben Gouaux5, Heather Bentley5 and J Hampton Atkinson5, “Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial” Revised 28 June 2008

1Department of Neurosciences, University of California, San Diego, CA, USA

2Department of Family and Preventive Medicine, University of California, San Diego, CA, USA

3Department of Medicine, University of California, San Diego, CA, USA

4Department of Pharmacy, University of California, San Diego, CA, USA

5Department of Psychiatry, University of California, San Diego, CA, USA

Correspondence: Dr RJ Ellis, Department of Neurosciences, University of California, San Diego, 150 W Washington St., San Diego, CA 92103 USA. Tel: +1 619 543 5079; Fax: +1 619 543 4744; E-mail: roellis@ucsd.edu

Ellenberger, “Treatment of human spasticity with delta-9-tetrahydrocannbinol.” Journal of Clinical Pharmacology, August 21, 1981

“Environmental Catch-22.” Editorial, The Toledo Blade, July 31, 1999

Erasemus, Fats that Heal, Fats that Kill. BC, Canada: Alive Books, 1993

Fackelman, “Marijuana and the brain: scientists discover the brain’s own THC.” Science News, Vol. 143, No. 6, p. 88, February 6, 1993

“FBI reports on marijuana arrests exceeded those for violent crime.” NORML News, October 21, 1999

“Federal report reignites medical marijuana debate.” CNN, March 17, 1999

Finn, “Cannabinoid investigations entering the mainstream.” The Scientist, Vol. 12, No. 3, pp. 1-8, February 2, 1998

Formukong, Evans, and Evans, “Analgesic and anti-inflammatory activity of constituents of Cannabis sativa L.”Inflammation, Vol. 12, No. 4, p. 361-371, 1988

“Functional role of cannabinoid receptors.” Symposium Syllabus Press Conference, August 26, 1998

“Functional role of high-affinity anandamide transport, as revealed by selective inhibition.” Science, Vol. 227, No. 5329, p. 1094(4), August 22, 1997

Gagnon, “Marijuana less harmful to lungs than cigarettes.” Medical Post (Quebec), September 6, 1994

Gerhard, “Sense and Sinsemilla.” POZ Magazine, June 1999

Gettman, “The tolerance factor.” High Times, No. 239, July 1995

Gettman, Drug Abuse, Cannabis, and the Brain. New York: Trans High Corporation, 1997. Source: www.hightimes.com/ht/tow/med/brain.html

Gettman, “Marijuana and the human brain.” High Times, March 1995. Source: www.hightimes.com, www.umsl.edu/~keel/180/brain1.html

Gettman, “Marijuana, Science, and Public Policy.” July 11, 1997. Source: www.norml.org/facts/mspp.shtml

Gettman, “The Tolerance Factor.” High Times, No. 239, July 1995

Gettman, “Tolerance to Cannabinoids.” High Times. Source: www.hightimes.com/ht/new/petition/jgpetition/c3e.html

Geiringer, “An overview of the human research studies on medical use of marijuana.” 1994. Source: CANORML, www.norml.org/canorml/

Geiringer, “Marijuana Water Pipe and Vaporizer Study.” MAPS Bulletin, 1996. Source: CANORML, www.norml.org/canorml/

Gifford, Gardner, and Ashby, “The effects of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A 10 dopamine neurons recorded in vivo in anesthetized rats.” Neuropsychopharmacology, Vol. 36, No. 2, 99. 96-99, 1997. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Gilson and Busalacchi, “Marijuana for intractable hiccups.” The Lancet, Vol. 351, No. 9098, January 24, 1998. Source: Aurora Medical Group, Milwaukee, WI 53212

Green and Roth, “Ocular effects of topical administration of delta-9-tetrahydrocannabinol in man.” Archives of Opthamology, Vol. 100, No. 2, pp. 265-267, February 1992

Grinspoon, Affidavit before Judge Riccardo Martinez, King County Superior Court (WA), September 26, 1997

Grinspoon, “Anecdotal surveys on diabetes.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon, “Marijuana and asthma.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon, “Marijuana and heroin addiction.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon, “Marijuana and migraine.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon, “Marijuana for intractable hiccoughs.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon, Marijuana Reconsidered, 3^rd ed. San Francisco: Quick American Archives, 1971

Grinspoon, “Multiple Sclerosis.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon, Science, 1997. Source: The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon and Bakalar, “Marijuana: an old medicine of the future.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon and Bakalar, Marijuana, The Forbidden Medicine. New Haven: Yale University Press, 1993

Grinspoon and Bakalar, Medical Uses of Illicit Drugs, 1997. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Grinspoon, Bakalar, Zimmer, and Morgan, “Marijuana addiction.” Science, Vol. 277, pp. 749, August 8, 1997

Grinspoon and Christine, “Marijuana and irritable bowel syndrome.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon and Kluge, “Marijuana and Crohn’s Disease.” The Forbidden Medicine Website, www.rxmarijuana.com

Grinspoon and Wilson, “Marijuana and bipolar disorder.” The Forbidden Medicine Website, www.rxmarijuana.com

Grotenhermen, “Effects of Cannabis and the Cannabinoids.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 5, p. 56-57, 59-62

Grotenhermen, “Review of Therapeutic Effects.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 11, p. 125-132, 134

Grotenhermen, “Review of Unwanted Actions of Cannabis and THC.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 21, p. 233-234

Grotenhermen, Russo. Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002

Guara, “Legal hassles extinguishing pot clubs.” San Francisco Chronicle, May 23, 1998

Guimares, “Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.” General Pharmacology, Vol. 25, pp. 161-164, 1994

Hampson, “Cannabinoids As Neuroprotectants Against Ischemia.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential New York: The Hawthorn Integrative Healing Press, 2002, Chapter 9, p. 102-103, 105-106

Hannington, “Migraine, a blood disorder.” The Lancet, Vol. 1, No. 501, 1978

“Hashish evidence is 1,600 years old.” Associated Press, June 2, 1992

“The health and psychological consequences of cannabis use.” National Drug Strategy Monograph No. 25, Chapter 6, Australia. Source: Schaffer Library of Drug Policy, www.druglibrary.org

“Health care use by frequent marijuana smokers who do not smoke tobacco.” Western Journal of Medicine, Vol. 158, No. 6, pp. 596-601, June 1993. Source: Geiringer, Marijuana Health Mythology, 1994, CANORML, www.norml.org/canorml

“Heavy long term marijuana use does not impair lung function, says new study.” Los Angeles Times, May 3, 1997

“High expectations for stroke drug.” Israel Business Today, Vol. 8, No. 387, pp. 19, July 24, 1998

High Times , p. 34, May 1998

“History of marijuana use: medical and intoxicant.” A Signal of Misunderstanding, Report of the U.S. National Commission on Marijuana and Drug Abuse, 1972. Source: Schaffer Library on Drug Policy, www.druglibrary.org

Hodges, “Migraine.” The Forbidden Medicine Website, www.rxmarijuana.com

Holdcroft, et. al. “Pain relief with oral cannabinoids in familial Mediterranean fever.” Anaesthesia, Vol. 52, No. 5, pp. 483-486, May 1997

Holdcroft, “Pain Therapy.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 15, p. 182, 184

Hollister, “Health aspects of marijuana.” Pharmacological Review, Vol. 38, No. 1, 1986

Hollister, “Marijuana and immunity.” Journal of Psychoactive Drugs, Vol. 24, pp. 159-63, 1992

Hooker and Jones, “Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication.” Psychopharmacology, Vol. 91, No. 1, pp. 20-24, 1987

Hotz, “Study confirms pot chemicals can relieve serious pain.” Los Angeles Times, October 27, 1997

Institute of Medicine, Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press, 1999

Jacobson, “US deaths from AIDS dropped 12% in period, study finds.” Dallas Morning Star, February 28, 1998

James, “Medical marijuana: Unpublished federal study found THC treated rats live longer, had fewer cancers.” AIDS Treatment News, January 17, 1997

Jay and Green, “Multiple-drop study of topically applied 1% delta-9-tetrahydrocanabinol in human eyes.” Archives of Opthamology, Vol. 101, No. 4, pp. 591-593, April 1993

Johnston, “Elderly mixing up television, reality: Study: Violent images on the tube and disorienting seniors.” London Observer. Source: San Francisco Examiner, May 26, 1998

Johnston, T., “It’s not the cancer that’s killing her.” November Coalition discussion list, Spring 1998, November Coalition, www.november.org

Jones, Benowitz, and Herning, “Clinical relevance of cannabis tolerance and dependence.” Journal of Clinical Pharmacology, (8-9 Suppl) p. 143S-152S, August 21, 1981. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Jordan, “The luckiest woman on Earth.” Highwitness News, High Times, No. 266, October 1997

“Judge says jailed medical marijuana advocate must receive medical attention.” Associated Press, August 1, 1998

“Judge told to rethink marijuana ban.” Associated Press, September 14, 1999

Kaiser Permanente Public Information Release, KRCB in San Francisco, July 7, 1998

Kaisirer, ed., “Federal foolishness and marijuana.” New England Journal of Medicine, January 30, 1997

Kaslow, et al., “The probable health effects of cannabis use.” World Health Organization Project on Health Implications of Cannabis Use: A Comparative Appraisal of the Health and Psychological Consequences of Alcohol, Cannabis, Nicotine, and Opiate Use, II. December 1997. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Kleiman, Against Excess: Drug Policy for Results. New York: Basic Books, 1997

Klein, Stein, and Hutzler, “Cigarettes, alcohol, and marijuana: varying associations with birth weight.” International Association of Epidemiology, Vol. 16, No. 1, 1987

Klonoff, “Marijuana and driving in real life situations.” Science, Vol. 186, pp. 312-314, 1974.

Knox, “Study may undercut marijuana opponents: Report says THC did not cause cancer.” Boston Globe, January 30, 1997

Kolansky and Moore, 1971, Millman and Sbriglio, 1986, “The probable health effects of cannabis use.” World Health Organization Project on Health Implications of Cannabis Use: A Comparative Appraisal of the Health and Psychological Consequences of Alcohol, Cannabis, Nicotine, and Opiate Use, II. December 1997. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Komp, “Babies born to marijuana smoking mothers in Jamaica are found to be developmentally superior.” Source: Mount, ed. www.snowcrest.net/stlight/

Krassner, “Medical-pot ban threatens Peter McWilliam’s life.” High Times, July 1999

“Lab tests show cannabis clubs’ medical marijuana superior to government’s.” Press Release, CANORML, May 21, 1999, www.norml.org/canorml/

Label warning on “Pringles” package, 1998

Laino, “Waiting to inhale: hemp for health?” MSNBC News, Spring 1998

Lamont, “Study shows marijuana users as healthy as general population.” Sydney Morning Herald, February 18, 1997

Latimer, “Highwitness News.” NORML News, No. 270, p. 30, February 1998

Letter from American Cancer Society to CA Senator Vasconcellos, July 25, 1997

Leigh, “Study brings breath of fresh air to pot smokers.” Medical Tribune News Service, 1999

Lindesmith Center, 888 Seventh Avenue, NY, NY 10106, ww.lindesmith.org

London Free Press (Canada), May 8, 1997

“Long term marijuana users suffer few health problems, Australian study indicates.” NORML News, 1998, www.norml.org

Loveless, Harris, and Munson, “Hyporesponsiveness to the immunosuppressant effects of delta-9-tetrahydrocannabinol.” Journal of Immunopharmacology, Vol. 3, No. 3-4, pp. 371-383, 1981

Lyketsos, et al., “Cannabis use and cognitive decline in persons under 65 years of age.” American Journal of Epidemeology, Vol. 149, pp. 784-800, May 1, 1999

Marijuana Policy Project, www.mpp.org

Marinol product information from Roxane Laboratories, Inc., Columbus, OH 43216. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Martinez, “Chronic Pain.” The Forbidden Medicine Website, www.rxmarijuana.com/martinez.html

Martinez, “Meniere’s syndrome.” The Forbidden Medicine Website, www.rxmarijuana.com/meniere.htm

Martinez, “The case of Joanna McKee.” The Green Cross Lifevine, www.hemp.net/greencross/lifevine.html

Mason, Perez-Reyes, Mcbay, and Folz, “Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke.” Journal of Analytical Toxicity, Vol. 4, pp. 172-174, July 7, 1983

Mathew, Wilson, Coleman, Turkington, and DeGrado, “Marijuana intoxication and brain activation in marijuana smokers.” Life Science, Vol. 60, No. 23, pp. 2075-2089, 1997

Mathre, ed., Cannabis in Medical Practice. North Carolina and London: McFarland and Company, 1997

Mattes, Shaw, and Engleman, “Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults.” Chemical Senses, Vol. 19, No. 2, pp. 125-140, 1994

Maugh, “Inhaled form of insulin passes first test.” Los Angeles Times, Seattle Times, June 17, 1997

Maugh, “Similar effects found for pot, harder drugs.” Los Angeles Times: Science Focus, June 27, 1997

Maurer, Henn, Dittrich, and Hoffmann, “Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.” European Archive of Psychiatry and Neurological Science, Vol. 240, No. 1, pp. 1-4, 1990

McKee, Director of the Green Cross Patient Coop, Testimony in news print and in numerous television and public appearances in Washington State, 1992-1998

McPartland, “Microbiological contaminants of marijuana.” Vermont Alternative Medicine, 1994. Source: Journal of the International Hemp Association, Vol. 1, pp. 41-44

McWilliams, “In the war on drugs, a Red Cross is just another target.” www.petertrial.com

McWilliams, “Medical Marijuana and Me.” Source: The Forbidden Medicine Website, www.rxmarijuana.com

McWilliams, Testimony before the California Senate Medical Marijuana Distribution Summit, May 26, 1998. Source: California State Rules Committee

“Medical marijuana: doing the science.” Synapse, 1998. Source: www.itsa.ucsf.edu/synapse/

“Medical marijuana.” Town Meeting, KOMO TV, Seattle, March 7, 1997

“Medical use of whole cannabis.” Statement of the Federation of American Scientists, 1996

“Medicinal Marijuana Briefing Paper 1997-98.” Marijuana Policy Project, 1998, www.mpp.org

Meinck, Schonle, and Conrad, “Effects of cannabinoids on spasticity and ataxia in multiple sclerosis.” Journal of Neurology, Vol. 236, pp. 120-122, 1989

Melamede, “Possible Mechanisms in Autoimmune Diseases.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 10, p. 113-114

“Mental fuzziness linked to marijuana.” Chicago Tribune, February 21, 1996

Merritt, Perry, Russell, and Jones, “Topical delta-9-tetrahydrocannabinol and aqueous dynamics in glaucoma.” Journal of Clinical Pharmacology, (8-9 Suppl) pp. 467S-471S, August 21, 1981

Mikuriya, “Chronic Migraine Headache: Five cases successfully treated with Marinol and/or illicit cannabis.” Berkeley, 1991. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Mikuriya, Medical Marijuana Handbook. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Mikuriya, Marijuana Papers. Oakland: Medi-comp Press, 1973

Mikuriya, Testimony during a medical necessity trial in the State of Washington. December 1996

Mikuriya, “Dependency and Cannabis.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 20, p. 225-228

Minton, “US agents raid Peron’s pot farm.” San Francisco Chronicle, May 15, 1998

Morin, “Research into cannabinoids provides evidence that the use of marijuana to treat pain and nausea should not be so easily dismissed.” May 1998. Source: morin@brown.edu

Mount, ed., “Introduction to cannabis and childbirth.” www.snowcrest.net/stlight

“MS patients to receive whole smoked marijuana in English trials.” NORML News, July 30, 1998

Muller-Vahl, Kolbe, Schnider, and Emrich, “Movement Disorders.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 18, p. 205-210

Musty and Consroe, “Spastic Disorders.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 17, p. 196-197, 199

National Academy of Science, “The health and psychological consequences of cannabis use.” Chapter 6, National Drug Strategy Monograph, No. 25, Australia. Source: Schaffer Library of Drug Policy, www.druglibrary.org

National Cancer Institute, Marijuana Use in Supportive Care for Cancer Patients. Cancer Information Service, September 1997. Source: www.cancernet.nci/nci 1-800-4-CANCER

“National drug war leaders disregard science in medicinal marijuana debate.” Marijuana Policy Project press release, April 20, 1999. Source: www.mpp.org

Nature , Vol. 363, May 20, 1993

Nelson, “A critical review of the research literature concerning some biological and psychological effects of cannabis.” Advisory Committee on Illicit Drugs, Cannabis and the Law in Queensland: Criminal Justice Commission of Queensland, Australia, 1993. Source: Schaffer Library of Drug Policy, www.druglibrary.org

“New Jersey man claims Viagra vision problem caused car crash.” Associated Press, July 28, 1998

“New lifesaving drugs explored as possible culprit.” Associated Press, May 14, 1998

“New research published by Federation of American Scientists finds marijuana offenders crowding nation’s prisons and jails.” Marijuana Policy Project, June 16, 1999

“New Scientist Sepecial Report on Marijuana.” New Scientist, February 21, 1998

“NIH Panelists Agree: Marijuana is Safe and Effective Medicine.” MPP News, August 4, 1997, Marijuana Policy Project, www.mpp.org

“Noam Chomsky on Renee Boje.” Hemp-talk, September 6, 1999, www.hemp.net

NORML News , www.norml.org

Noyes and Baram, “Cannabis analgesia.” Comprehensive Psychiatry.” Vol. 15, No. 6, 1974

Noyes, Brunk, Baram, and Canter, “Analgesic effect of delta-9-tetrahydrocannabinol.” Journal of Clinical Pharmacology, Vol. 2, No. 3, pp. 139-143, February 15, 1975

“NY State Legislator and Head of NY Hospital’s Department of Public Health Supports Medical Marijuana.” Source: Cowen, www.marijuananews.com, January 1998

Oakland City Council Resolutions on Medical Marijuana.” Reuters, March 17, 1999

Orr, Mckernan, and Bloome, “Anti-emetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emisis.” Archives of Internal Medicine, Vol. 140, No. 11, pp. 1431-1433, November 1980. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Osborn, “Hempseed: Nature’s perfect food?” High Times, pp. 36-39, 50-51, 55, 56, April 1992

“Painkiller can harm liver, FDA warns.” Associated Press, February 11, 1998

Palella, et al., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus.” New England Journal of Medicine, Vol. 338, No. 13, p. 853, March 26, 1998

Pan, “On the origin of papermaking in the light of research on recent archeological discoveries.” Newsletter of the Friends of Dard Hunter Paper Museum, June 1987

“Parkinson’s drug may spur hallucinations.” Reuters Health Information, May 11, 1998

Partnership for a Drug Free America, public information television release, May 1998

Pate, “Glaucoma and Cannabinoids.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 19, p. 216-219

Pertwee, Letters, The Scotsman, February 19, 1998. Source: Cowen, www.marijuananews.com

Petro, “Marijuana as a therapeutic agent for muscle spasm or spasticity.” (Case reports) 1980. Source: D.J. Petro, MD, 1158 Lydig Avenue, Bronx, NY 10461

Petro and Ellenberger, “References on Multiple Sclerosis and Marijuana.” 1998. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Petro and Ellenberger, “Treatment of Human Spasticity with Delta-9-tetrahydrocannabinol.” Journal of Clinical Pharmacology, Vol. 21, pp. 413S-416S, 1981. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Physician’s Desk Reference of Pharmaceutical Products , Montvale, NJ, Economics Data Production Co., 1994

Piomelli, “Functional role of high-affinity anandamide transport, as revealed by selective inhibition.” Science, Vol. 227, No. 5329, p. 1094(4), August 22, 1997

“Planet Science: Marijuana Special Report.” New Scientist, February 21, 1998

Plasse, “Antiemetic Effects of Cannabinoids.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 14, p. 174

Portyansky, Plant of a Thousand Uses (Marijuana). Medical Economics Publishing, 1998, E. Collection: A20409468

Poster, Penta, Bruno, and Macdonald,, “Delta-9-tetrahydrocannabinol in clinical oncology.” Journal of the American Medical Association, Vol. 245, No. 20, pp. 2047-2051, May 22, 1998

“Pot chemical can relieve serious pain.” Los Angeles Times, August 27, 1998

“Pot garden size brought case to court.” Sonora Union Democrat (California), March 19, 1998

“Pre-clinical studies show CT-3 reduces chronic and acute inflammation and reduces destruction of joints.” BW HealthWire, January 1998, Source: Cowen, www.marijuananews.com

“Prisons can’t cure drug problem, doctors tell US.” Miami Herald, Herald Washington Bureau, March 18, 1998

Quinn, “Court Boosts Medical Marijuana Clubs.” Reuters, September 13, 1999

Radford (Science Editor), “UN Study Suppressed.” The San Francisco Guardian, February 18, 1998

Radford, T., “Cannabis is stoke hope.” The Guardian (UK), July 4, 1998

Randall, Affidavit before Administrative Law Judge Francis L. Young of the US Drug Enforcement Administration, Marijuana Medicine and the Law. Washington, DC: Galen Press, 1988

Randall, Cancer Treatment and Marijuana Therapy. Washington, DC: Galen Press, 1990

Randall, ed., Marijuana Medicine and the Law. Washington, DC: Galen Press, 1998, Alliance for Cannabis Therapeutics, PO Box 19161, Sarasota, FL 34276

“Researchers say many cancer patients suffer needless pain.” Associated Press, June 17, 1998

“Researchers watch dopamine changes in brain of video game players.” Associated Press, May 21, 1998

Robbe, “Marijuana use and driving.” Institute for Human Psychopharmacology, University of Limburg, 1994

Robberson, “US pushes plan to apply poison on Columbian fields.” Dallas Morning News, April 25, 1998

Robinson, The Great Book of Hemp. Vermont: Park Street Press, 1996

Robson, “Cannabis as medicine: time for the phoenix to rise?” British Medical Journal, Vol. 316, No. 7137, p. 1034(2), April 4, 1998

Rosenthal, Geiringer, Mikuriya, MD, Marijuana Medical Handbook: A Guide to Therapeutic Use. San Francisco: Quick American Archives, 1997

Rossi, Kuehnle, and Mendelson, “Marijuana and mood in human volunteers.” Pharmacological Biochemistry and Behavior, Vol. 4, pp. 447-453, 1978. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Sallen, Zinberg, and Frei, “Anti-emetic effects of Delta-9 THC in patients receiving cancer chemotherapy.” New England Journal of Medicine, Nol. 296, No. 16, 1975

San Francisco Chronicle, San Francisco Examiner , Associated Press, 1998

Schaeffer, Andrysiak, and Ungerleider, “Cognition and Long Term Use of Ganja.” Science, Vol. 213, pp. 465-466, July 24, 1981

Schlosser, “The politics of pot: A government in denial.” Rolling Stone, March 4, 1999

Schnelle and Strasser, “Anorexia and Cachexia.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 13, p. 158-160

Seeley, Town Meeting, KOMO TV 4 in Seattle, March 9, 1997

Smith, Paithirana, Davidson, et. al., The Origin of Hepatitis C Genotypes. Department of Medical Microbiology, University of Edenburgh Medical School, UK, 1997

Statement of Dr. Richard Cohen, Consulting Medical Oncologist, California-Pacific Medical Center, San Francisco. Source: Californians for Medical Rights

Stein, “Bits and Pieces.” Geriatric Psychiatric News, Issue 3, No. 7, June/July 1999

Stolberg, “Study finds elderly receive little pain treatment in nursing homes.” June 17, 1998

“Study reveals pot chemicals can relieve serious pain.” Los Angeles Times, October 27, 1998

Symposium Syllabus: Functional role of cannabinoid receptors . Press Conference, August 26, 1998. Source: Medical Marijuana Magazine, www.marijuanamagazine.com

Taber’s Cyclopedic Medical Dictionary . Philadelphia: F.A. Davis Company, 1987

Tashkin, “Is frequent marijuana smoking hazardous to health?” Western Journal of Medicine, Vol. 158, No. 6, pp. 635-637

Tashkin, et al., “Effects of habitual use of marijuana and/or cocaine on the lung.” Research findings on smoking of abused substances, NIDA Research Monograph 99, 1990

Tashkin, Shapiro, Lee, and Harper, “Effects of smoked marijuana in experimentally induced asthma.” American Review of Respiratory Disease, Vol. 112, 1975

Terhune et al., “The incidence and role of drugs in fatally injured drivers.” Accident Research Group, #DOT-HS-808-065, Buffalo, NY. Source: National Technical Information Service, Springfield, VA 22161

“The health and psychological consequences of cannabis use.” National Drug Strategy Monograph No. 25, Chapter 6, Australia

“The July 1995 Gettman/High Times petition to repeal marijuana prohibition: An extensive review of relevant legal and scientific findings.” Source: High Times, www.hightimes.com/ht/new/petition/jgpetition/index.html

The testimony of hundreds of medical marijuana patients interviewed by the author.

“Therapeutic possibilities in cannabinoids.” Editorial, The Lancet, pp. 667-669, March 22, 1975

Tye, “Marijuana product may aid in traumas.” Boston Globe, October 7, 1998

U.S. Code Congressional and Administrative News , 1970

U.S. Congress OTA, 1993. Source: Gettman, Marijauna, Science, and Public Policy, www.norml.org/facts/mspp.shtml

U.S. Department of Justice, Drug Enforcement Administration, Cannabis Eradication in the Contiguous United States and Hawaii.

U.S. Department of Justice, Drug Enforcement Administration, Statement of Policy for the Use and Handling of Controlled Substances in the Treatment of Pain, 1998

“U.S. study: marijuana is addictive.” Reuters, March 31, 1998

“U.S. study: marijuana might protect the brain.” Reuters, July 6, 1008

“UN says HIV more widespread than thought.” Associated Press, November 26, 1997

Undocumented case of Vietnam Veteran Fenly Crawford

Ungerleider, Andrysiak, Fairbanks, Ellison, and Myers, “Delta-9-THC n the treatment of spasticity associated with multiple sclerosis.” Advisory on Alcohol and Substance Abuse, Vol. 7, No. 1, pp. 39-50, 1987

Vaughn and Christie, “Mechanisms of Cannabinoid Analgesia.” Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002, Chapter 8, p. 90, 93, 95

Vinciguerra, Moore, and Brennen, “Inhalation of Marijuana as an anti-emetic for chemotherapy.” New York State Journal of Medicine, Vol. 88, pp. 525-527, 1988

Volve, Dvilansky, and Nathan, “Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients.” International Journal of Clinical Pharmacology, Vol. 4, pp. 243-246, 1985

Ward, “Birth of an Olympian.” 1998

Warden, “UK will speed up work on cannabis.” The British Medical Journal, May 5, 1998

Widener, “Study: Marijuana, morphine might work on same area of the brain.” The Seattle Times, September 25, 1998

Williams, Boulton, de Pemberton, and Whitehouse, “Antiemetics for patients treated with antitumor chemotherapy.” Cancer Clinical Trials, Vol. 3, No. 4, pp. 363-367, 1980. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Willman, “Fast track diabetes drug tied to 33 deaths.” Los Angeles Times, December 6, 1998

Wirtschafter, “A hempen birthing.” Source: Mount, ed., www.snowcrest.com/stlight/

Wirschafter, “Why Hemp Seeds?” Hemp Today, Rosenthal, ed. Quick Trading Company, PO Box 429477, San Francisco CA 94142, 1994

Wishnia, “The IOM medical-marijuana report.” High Times, July 1999

“The probable health effects of cannabis use.” World Health Organization Project on Health Implications of Cannabis Use: A Comparative Appraisal of the Health and Psychological Consequences of Alcohol, Cannabis, Nicotine, and Opiate Use, II. Source: Schaffer Library of Drug Policy, www.druglibrary.org

Wu, Wright, Sassoon, and Tashkin, “Effects of smoked marijuana of carrying potency on ventilatory drive and metabolic rate.” American Revue of Respiratory Disease, Vol. 146, No. 3, pp. 716-721, 1992. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Young, DEA Administrative Law Judge, Findings. Source: Randall, ed., Marijuana Medicine and the Law. Washington, DC: Galen Press, 1988

Zimmer and Morgan, Marijuana Myths: Marijuana Facts. New York: The Lindesmith Center, 1997

Zuardi et al., “Action of cannabidiol on the anxiety and other effects produced by delta-9 THC in normal subjects.” Psychopharmacology, Vol. 76, pp. 245-250. Source: National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/

Zuardi et al., “Effects of ipsapirone and cannabidiol on human experimental anxiety.” Journal of Psychopharmacology, Vol. 7, pp. 82-88. Source: National Library Mediciene, www.ncbi.nlm.nih.gov/pubmed/